Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00506974 · ClinicalTrials.gov registry record · Phase 4
Enhancing Slow Wave Sleep With Sodium Oxybate
A Phase 4 study, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00506974 is a Phase 4 study that has completed, run by St. Luke's Hospital, Chesterfield, Missouri. The registered enrollment target is 60 participants.
The verdict
NCT00506974, a Phase 4 study, has completed, sponsored by St. Luke's Hospital, Chesterfield, Missouri.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if there the impact of sleep deprivation upon sleepiness, attention, memory, and mood is reduced by pharmacologically enhancing slow wave sleep (SWS) with sodium oxybate.
Interventions
- DRUG sodium oxybate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00506974
The ClinicalTrials.gov registry entry for NCT00506974 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital, Chesterfield, Missouri, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium oxybate is the first listed.
NCT00506974 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00506974 about?
NCT00506974 is a clinical study titled "Enhancing Slow Wave Sleep With Sodium Oxybate". The purpose of this study is to determine if there the impact of sleep deprivation upon sleepiness, attention, memory, and mood is reduced by pharmacologically enhancing slow wave sleep (SWS) with sodium oxybate.
What is the current status of trial NCT00506974?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-05. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00506974?
The interventions under investigation include: sodium oxybate (DRUG).
Who is sponsoring clinical trial NCT00506974?
This trial is sponsored by St. Luke's Hospital, Chesterfield, Missouri, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.